Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DSPE-PEG(2000)-mannose is a PEGylated and mannosylated form of 1,2-distearoyl-sn-glycero-3-PE (1,2-DSPE; Item No. 15095) that has been used in the generation of liposomes and lipid nanoparticles (LNPs) for the delivery of peptides, oligodeoxynucleotides, and siRNA in vitro and in vivo.1,2 Fluorescently labeled LNPs containing DSPE-PEG(2000)-mannose selectively accumulate in the liver and spleen over the brain, lungs, heart, kidney, and pancreas in mice.1 Immunization with liposomes containing DSPE-PEG(2000)-mannose and encapsulating human papilloma virus type 16 (HPV16) E7 peptide and CpG oligodeoxynucleotide as an adjuvant decrease tumor size, intratumoral CD4+ or CD8+ T cells, and intratumoral angiogenesis in a murine lung cancer model using TC-1 cells, which express HPV16 E6 and E7 peptides.2
WARNING This product is not for human or veterinary use.
1. Optimization of polyethylene glycol shielding and mannose density on the lipid nanoparticles for efficient delivery to macrophages and spleens. Int. J. Pharm. 662, 124540 (2024).
2. Mannose-